Recent Updates

Modified on: 
Aug 16, 2019

The BloodTechNet program was launched in 2011 to facilitate the development of innovative educational resources that support the Transfusion, Cellular Therapy and Transplantation communities in Canada. The program is led by Canadian Blood Services’ Centre for Innovation with financial support from Grifols. For information about the next BloodTechNet program competition, visit blood.ca research funding programs.

Transfusion
Organs and Tissues
Stem Cells
Modified on: 
Aug 14, 2019

Author: Rob Romans, ART, BSc
Online publication date: August 2019

Background

In August 2018, the National Advisory Committee on Blood and Blood Products (NAC) endorsed the document “Guidance on Platelet Transfusion for Patients With Hypoproliferative Thrombocytopenia” published by the International Collaboration for Transfusion Medicine Guidelines (ICTMG).1, 2, 3

Transfusion
Modified on: 
Aug 8, 2019

Author: Rachel Ward, JD, BCom
Online publication date: August 2019
Target audience: health-care professionals and academics conducting research projects involving human participants.

This article provides health-care professionals and researchers with an overview of the frameworks that help protect individuals’ privacy in the context of research, a topic that is particularly relevant in a time of big data, artificial intelligence and significant advances in technologies that are reliant on data inputs.

Transfusion
Modified on: 
Aug 8, 2019

All blood transfused in Canada is collected from volunteer donors. To ensure the safety of the blood products, donors are carefully screened against an extended list of eligibility criteria. In addition, the donated blood is tested to identify the donor’s blood group and to detect blood group antibodies and transfusion-transmissible pathogens. Donor eligibility criteria and testing also benefit the donors by, for example, reducing potential blood donation-related health risks.

Transfusion
Modified on: 
Jul 10, 2019

A. Reporting

Attention: All transfusion reactions (mild to life-threatening) and transfusion-related errors must be reported to the hospital’s transfusion service (blood bank).

What:

Transfusion
Modified on: 
May 29, 2019

Author: Rob Romans 
Publication date: March 2019  

The primary target audience for this educational resource: Medical Laboratory Technologist (MLT) in the hospital laboratory, Prescribers of cryoprecipitates. 

Transfusion
Modified on: 
May 21, 2019

We are pleased to provide on a regular basis a Surveillance Report describing infectious disease surveillance that our stakeholders can consult to make evidence-based decisions.

High quality and timely surveillance is key to the safety of the blood supply. This includes monitoring of transmissible disease markers that the blood is tested for (including bacteria), investigation of any reports of possible transfusion transmission, as well as a horizon scan for any new pathogens that may pose a risk now or in the future.

Transfusion
Modified on: 
May 13, 2019

This first chapter of the Clinical Guide to Transfusion provides an overview of the blood system in Canada, the regulations and standards that are in place and the organizations and professionals that, together, ensure transfusion medicine safety for Canadian patients. 

Transfusion
Modified on: 
May 13, 2019

Author: Mindy Goldman, MD, FRCPC
Online publication date: March 2012, updated July 2018

Transfusion
Modified on: 
Apr 17, 2019

Anti-Le, commonly anti-Lea, Leb, or Leab, are antibodies directed to antigens of the Lewis blood group system. The Lewis antigens are glycoproteins that are found on the surface of many cells and secreted in various body fluids. As such, Lewis, along with ABO and H are sometimes referred to as “histo-blood groups,” given the fact they are present on many different tissue types.

Transfusion

Pages